Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanno Glimm

Showing results (51-60 of 148) with videos related to

Pageof 15
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|August 30, 2021
YAP-induced Ccl2 expression is associated with a switch in hepatic macrophage identity and vascular remodelling in liver cancerStefan Thomann, Sofia M E Weiler, Teng Wei, et al.
Cell Death and Differentiation|March 27, 2025
The histone modifier KAT2A presents a selective target in a subset of well-differentiated microsatellite-stable colorectal cancersVida Kufrin, Annika Seiler, Silke Brilloff, et al.
Cancer Research|January 8, 2013
Specific elimination of CD133+ tumor cells with targeted oncolytic measles virusPatricia Bach, Tobias Abel, Christopher Hoffmann, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 22, 2012
Extensive methylation of promoter sequences silences lentiviral transgene expression during stem cell differentiation in vivoFriederike Herbst, Claudia R Ball, Francesca Tuorto, et al.
Cell Stem Cell|October 11, 2011
Distinct types of tumor-initiating cells form human colon cancer tumors and metastasesSebastian M Dieter, Claudia R Ball, Christopher M Hoffmann, et al.
Cell Stem Cell|July 7, 2018
Mapping Active Gene-Regulatory Regions in Human Repopulating Long-Term HSCsPeer Wünsche, Elias S P Eckert, Tim Holland-Letz, et al.
Cold Spring Harbor Molecular Case Studies|August 27, 2020
Successful BRAF/MEK inhibition in a patient with <i>BRAF</i><sup>V600E</sup>-mutated extrapancreatic acinar cell carcinomaElena Busch, Simon Kreutzfeldt, Abbas Agaimy, et al.
Cell Death Discovery|October 20, 2025
Cell cycle regulator MYBL2 is a distinct vulnerability in acute myeloid leukemiaSandra Küchler, Silke Brilloff, Silvia Schäfer, et al.
Cell Reports|August 24, 2017
Asymmetric Centriole Numbers at Spindle Poles Cause Chromosome Missegregation in CancerMarco R Cosenza, Anna Cazzola, Annik Rossberg, et al.
The Journal of Experimental Medicine|March 28, 2012
Targeting of KRAS mutant tumors by HSP90 inhibitors involves degradation of STK33Ninel Azoitei, Christopher M Hoffmann, Jana M Ellegast, et al.
Pageof 15

Showing results (51-60 of 148) with videos related to

Sort By:
Pageof 15
Liver International : Official Journal of the International Association for the Study of the Liver|August 30, 2021
YAP-induced Ccl2 expression is associated with a switch in hepatic macrophage identity and vascular remodelling in liver cancerStefan Thomann, Sofia M E Weiler, Teng Wei, et al.
Cell Death and Differentiation|March 27, 2025
The histone modifier KAT2A presents a selective target in a subset of well-differentiated microsatellite-stable colorectal cancersVida Kufrin, Annika Seiler, Silke Brilloff, et al.
Cancer Research|January 8, 2013
Specific elimination of CD133+ tumor cells with targeted oncolytic measles virusPatricia Bach, Tobias Abel, Christopher Hoffmann, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 22, 2012
Extensive methylation of promoter sequences silences lentiviral transgene expression during stem cell differentiation in vivoFriederike Herbst, Claudia R Ball, Francesca Tuorto, et al.
Cell Stem Cell|October 11, 2011
Distinct types of tumor-initiating cells form human colon cancer tumors and metastasesSebastian M Dieter, Claudia R Ball, Christopher M Hoffmann, et al.
Cell Stem Cell|July 7, 2018
Mapping Active Gene-Regulatory Regions in Human Repopulating Long-Term HSCsPeer Wünsche, Elias S P Eckert, Tim Holland-Letz, et al.
Cold Spring Harbor Molecular Case Studies|August 27, 2020
Successful BRAF/MEK inhibition in a patient with <i>BRAF</i><sup>V600E</sup>-mutated extrapancreatic acinar cell carcinomaElena Busch, Simon Kreutzfeldt, Abbas Agaimy, et al.
Cell Death Discovery|October 20, 2025
Cell cycle regulator MYBL2 is a distinct vulnerability in acute myeloid leukemiaSandra Küchler, Silke Brilloff, Silvia Schäfer, et al.
Cell Reports|August 24, 2017
Asymmetric Centriole Numbers at Spindle Poles Cause Chromosome Missegregation in CancerMarco R Cosenza, Anna Cazzola, Annik Rossberg, et al.
The Journal of Experimental Medicine|March 28, 2012
Targeting of KRAS mutant tumors by HSP90 inhibitors involves degradation of STK33Ninel Azoitei, Christopher M Hoffmann, Jana M Ellegast, et al.
Pageof 15